Real Labs, Actual Decisions With Actionable Six Sigma Metrics
QuidelOrtho (NASDAQ: QDEL) has announced a featured session at the upcoming Association for Diagnostics & Laboratory Medicine (ADLM) meeting, focusing on Six Sigma metrics in laboratory performance. The session, titled "Real Labs, Real Decisions with Actionable Six Sigma Metrics," will take place on July 29, 2025 at the McCormick Convention Center in Chicago.
The panel discussion will feature experts including Dr. Jared Jaeger as moderator, along with distinguished professionals from the University of Florida PathLab, St. Peter's University Hospital, and UHS Hospitals. The session will explore how QuidelOrtho's Six Sigma tools and real-world laboratory data can be utilized to enhance quality outcomes in clinical settings.
QuidelOrtho (NASDAQ: QDEL) ha annunciato una sessione speciale al prossimo incontro dell'Association for Diagnostics & Laboratory Medicine (ADLM), incentrata sulle metriche Six Sigma nella performance di laboratorio. La sessione, intitolata "Laboratori Reali, Decisioni Reali con Metriche Six Sigma Utili", si terrà il 29 luglio 2025 presso il McCormick Convention Center di Chicago.
Il panel includerà esperti come il dott. Jared Jaeger in qualità di moderatore, insieme a professionisti di rilievo provenienti dall'University of Florida PathLab, dal St. Peter's University Hospital e dagli UHS Hospitals. La sessione analizzerà come gli strumenti Six Sigma di QuidelOrtho e i dati di laboratorio reali possano essere impiegati per migliorare i risultati qualitativi negli ambienti clinici.
QuidelOrtho (NASDAQ: QDEL) ha anunciado una sesión destacada en la próxima reunión de la Association for Diagnostics & Laboratory Medicine (ADLM), centrada en las métricas Six Sigma en el desempeño de laboratorio. La sesión, titulada "Laboratorios Reales, Decisiones Reales con Métricas Six Sigma Accionables", se llevará a cabo el 29 de julio de 2025 en el McCormick Convention Center en Chicago.
La mesa redonda contará con expertos, incluyendo al Dr. Jared Jaeger como moderador, junto con profesionales destacados de University of Florida PathLab, St. Peter's University Hospital y UHS Hospitals. La sesión explorará cómo las herramientas Six Sigma de QuidelOrtho y los datos reales de laboratorio pueden utilizarse para mejorar los resultados de calidad en entornos clínicos.
QuidelOrtho (NASDAQ: QDEL)는 다가오는 진단 및 실험실 의학 협회(ADLM) 회의에서 실험실 성과의 식스 시그마 지표에 초점을 맞춘 특별 세션을 발표했습니다. "실제 실험실, 실행 가능한 식스 시그마 지표로 실질적 결정"이라는 제목의 이 세션은 2025년 7월 29일 시카고 맥코믹 컨벤션 센터에서 열릴 예정입니다.
패널 토론에는 조정자로서 Jared Jaeger 박사를 비롯해 플로리다 대학교 PathLab, 세인트 피터스 대학 병원, UHS 병원의 저명한 전문가들이 참여합니다. 이 세션에서는 QuidelOrtho의 식스 시그마 도구와 실제 실험실 데이터를 활용하여 임상 환경에서 품질 성과를 향상시키는 방법을 탐구할 것입니다.
QuidelOrtho (NASDAQ: QDEL) a annoncé une session spéciale lors de la prochaine réunion de l'Association for Diagnostics & Laboratory Medicine (ADLM), axée sur les indicateurs Six Sigma dans la performance des laboratoires. La session, intitulée "Laboratoires Réels, Décisions Réelles avec des Indicateurs Six Sigma Exploitables", se tiendra le 29 juillet 2025 au McCormick Convention Center de Chicago.
La table ronde réunira des experts, dont le Dr Jared Jaeger en tant que modérateur, ainsi que des professionnels de renom de l'University of Florida PathLab, de l'hôpital universitaire St. Peter's et des hôpitaux UHS. La session explorera comment les outils Six Sigma de QuidelOrtho et les données réelles des laboratoires peuvent être utilisés pour améliorer les résultats qualitatifs en milieu clinique.
QuidelOrtho (NASDAQ: QDEL) hat eine Sonderveranstaltung auf dem bevorstehenden Treffen der Association for Diagnostics & Laboratory Medicine (ADLM) angekündigt, die sich auf Six-Sigma-Kennzahlen zur Laborleistung konzentriert. Die Sitzung mit dem Titel "Echte Labore, echte Entscheidungen mit umsetzbaren Six-Sigma-Kennzahlen" findet am 29. Juli 2025 im McCormick Convention Center in Chicago statt.
Die Podiumsdiskussion wird Experten wie Dr. Jared Jaeger als Moderator sowie angesehene Fachleute von der University of Florida PathLab, dem St. Peter's University Hospital und den UHS Hospitals umfassen. Die Sitzung wird untersuchen, wie QuidelOrthos Six-Sigma-Werkzeuge und echte Labordaten verwendet werden können, um die Qualitätsresultate in klinischen Umgebungen zu verbessern.
- None.
- None.
QuidelOrtho Announces Featured ADLM Session
ADLM Session Details:
Session Title: | Real Labs, Real Decisions with Actionable Six Sigma Metrics |
When: | Tuesday, July 29, 2025 |
Where: | McCormick Convention Center Exhibit Hall, Theater 1 |
Time: | 2:45 p.m. – 3:45 p.m. CT |
Registration: | Space is limited. ADLM attendees can register for the session using |
Real Labs, Real Decisions With Actionable Six Sigma Metrics Panelists:
Dr. Jared Jaeger
Clinical Science Liaison
QuidelOrtho
Moderator
Dr. Bremansu Osa-Andrews
Medical Director of Clinical
Chemistry and Clinical Assistant Professor
University of Florida PathLab
Gilles Attipoe
Director of Laboratory Services
Angela Armato
Core Lab Manager
United Health Services and UHS Hospitals
To learn more about Six Sigma and the value of using real-world data listen to "Sigma Metrics and the Value of Real World Evidence." In this podcast, QuidelOrtho data scientist Johanna Miller discusses how Six Sigma metrics are being adapted for the clinical laboratory.
Unable to attend ADLM? Register to watch a recording of the session: https://www2.na-ma.quidelortho.com/25-adlm-workshop-subscribe.
About QuidelOrtho
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed–from home to hospital, lab to clinic.
Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.
Investor Contact: Juliet Cunningham Vice President, Investor Relations | Media Contact: D. Nikki Wheeler Senior Director, Corporate Communications |
View original content to download multimedia:https://www.prnewswire.com/news-releases/real-labs-actual-decisions-with-actionable-six-sigma-metrics-302507241.html
SOURCE QuidelOrtho Corporation
FAQ
When and where is QuidelOrtho's ADLM session on Six Sigma metrics taking place?
Who are the panelists for QuidelOrtho's ADLM Six Sigma metrics session?
How can I register for QuidelOrtho's ADLM session if I'm unable to attend in person?
What is the main focus of QuidelOrtho's ADLM session?
